Kura Oncology, Inc.
Symbole: KURA
NASDAQ
20.59
USDPrix du marché aujourd'hui
-10.6467
Ratio P/E
-0.2997
Ratio PEG
1.57B
Cap MRK
- 0.00%
Rendement DIV
Kura Oncology, Inc. (KURA) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1880.65 | 424 | 438 | 518 | ||||||||||||||||
balance-sheet.row.short-term-investments | 1723.96 | 386.6 | 386.2 | 427.3 | ||||||||||||||||
balance-sheet.row.net-receivables | 2.8 | 2.8 | 0 | 0 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.other-current-assets | 32.43 | 5.7 | 8.4 | 4.3 | ||||||||||||||||
balance-sheet.row.total-current-assets | 1907.21 | 432.5 | 446.4 | 522.3 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 31.78 | 8.9 | 6.4 | 8.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0.61 | 0.2 | 0.2 | 0.2 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 23.08 | 7.4 | 3.3 | 3.3 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 55.47 | 16.5 | 9.9 | 11.8 | ||||||||||||||||
balance-sheet.row.other-assets | 8.67 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1971.35 | 448.9 | 456.3 | 534.1 | ||||||||||||||||
balance-sheet.row.account-payables | 6.4 | 2.3 | 1.5 | 3.2 | ||||||||||||||||
balance-sheet.row.short-term-debt | 6.9 | 1.5 | 2.3 | 2.3 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 51.38 | 9.3 | 11.7 | 4.6 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 109.76 | 31.5 | 20.2 | 17 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 60.43 | 16.4 | 12 | 5 | ||||||||||||||||
balance-sheet.row.other-liabilities | -23.9 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 25.89 | 6.4 | 4.9 | 6.9 | ||||||||||||||||
balance-sheet.row.total-liab | 155.48 | 51.7 | 36 | 27.4 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0.03 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.retained-earnings | -2811.11 | -721.4 | -568.8 | -433 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -10.84 | -1.3 | -8 | -1.8 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3514.16 | 1120 | 8 | 1.8 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 692.24 | 397.3 | -568.8 | -433 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 871.62 | 448.9 | -532.8 | -405.5 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 692.24 | 397.3 | -568.8 | -433 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 871.62 | - | - | - | ||||||||||||||||
Total Investments | 1724.16 | 386.8 | 386.2 | 427.3 | ||||||||||||||||
balance-sheet.row.total-debt | 64.64 | 17.2 | 14 | 6.9 | ||||||||||||||||
balance-sheet.row.net-debt | -92.05 | -20.1 | -37.8 | -83.8 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -168.09 | -152.6 | -135.8 | -130.5 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | -2.39 | 0.8 | 0.8 | 0.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -19.5 | 0 | 4.6 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 21.24 | 28.1 | 26.3 | 23.6 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 15.09 | 7.8 | -3 | -3.2 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.account-payables | 12.56 | 10.3 | -0.8 | -2.5 | ||||||||||||||||
cash-flows.row.other-working-capital | -0.6 | -2.5 | -2.2 | -0.7 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -7.37 | 10.5 | 1.7 | 0.4 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -137.8 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.22 | -0.2 | -0.6 | -1.1 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0.01 | -15.6 | 0 | 0.1 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -531.05 | -409.8 | -270.7 | -445.7 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 440.36 | 425.5 | 303.9 | 320 | ||||||||||||||||
cash-flows.row.other-investing-activites | -0.01 | 15.6 | 0 | -0.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -90.91 | 15.6 | 32.6 | -126.8 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -9.4 | -7.3 | ||||||||||||||||
cash-flows.row.common-stock-issued | 240.6 | 94.8 | 24.7 | 4.4 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 97.43 | 94.8 | 23.3 | -0.6 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 243.15 | 94.8 | 38.6 | -3.4 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 14.24 | -14.5 | -38.9 | -234.8 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 156.9 | 37.3 | 52 | 90.9 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 142.66 | 51.8 | 90.9 | 325.7 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -137.8 | -124.8 | -110.1 | -104.6 | ||||||||||||||||
cash-flows.row.capital-expenditure | -0.22 | -0.2 | -0.6 | -1.1 | ||||||||||||||||
cash-flows.row.free-cash-flow | -138.01 | -125 | -110.7 | -105.7 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1.27 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0.64 | 0.8 | 0.8 | 0.6 | ||||||||||||||||
income-statement-row.row.gross-profit | 0.63 | -0.8 | -0.8 | -0.6 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 126.31 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 57.38 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -0.21 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | -2.5 | 0 | 4 | 0.8 | ||||||||||||||||
income-statement-row.row.operating-expenses | 183.48 | 165 | 139.9 | 131.3 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 183.69 | 165.8 | 139.9 | 131.3 | ||||||||||||||||
income-statement-row.row.interest-income | 11.86 | 14.7 | 4.3 | 1.2 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.01 | 1.5 | 0.2 | 0.4 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -0.21 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 10.68 | 13.2 | 4.8 | 1.4 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | -2.5 | 0 | 4 | 0.8 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 10.68 | 13.2 | 4.8 | 1.4 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.01 | 1.5 | 0.2 | 0.4 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0.64 | 0.8 | 0.8 | 0.6 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -174.06 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -174.89 | -165.8 | -140.6 | -131.8 | ||||||||||||||||
income-statement-row.row.income-before-tax | -168.09 | -152.6 | -135.8 | -130.5 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 3.07 | 0 | 0.2 | -0.6 | ||||||||||||||||
income-statement-row.row.net-income | -168.09 | -152.6 | -136.1 | -129.9 |
Questions fréquemment posées
Quel est le total de Kura Oncology, Inc. (KURA) de l'actif total?
Kura Oncology, Inc. (KURA) Le total des actifs est 448935000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 1270000.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.331.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est -1.616.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est -117.767.
Quel est le revenu total de l'entreprise?
Le revenu total est -127.669.
Qu'est-ce que Kura Oncology, Inc. (KURA) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est -152631000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 17200000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 164955000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 41506000.000.